New case of phacomatosis cesio‐flammeo‐marmorata: the time is right to review the classification for phacomatosis pigmentovascularis

@article{Chehad2019NewCO,
  title={New case of phacomatosis cesio‐flammeo‐marmorata: the time is right to review the classification for phacomatosis pigmentovascularis},
  author={Ahmed S Chehad},
  journal={International Journal of Dermatology},
  year={2019},
  volume={58}
}
  • Ahmed S Chehad
  • Published 2019
  • Medicine
  • International Journal of Dermatology
  • lingual ulcers (rhagades). A biopsy of the labial mucosa showed granulomas of epithelioid cells and multinucleated giant cells, surrounded by lymphocytes, plasma cells, and polynuclear cells, with no detection of any pathogen, consistent with the diagnosis of GC (Fig. 1c,d). Infliximab was replaced by adalimumab (40 mg/2 weeks), which was maintained for 20 months with residual anoperineal lesions and no significant effect on GC, which required iterative treatments (clofazimine 200 mg/day… CONTINUE READING
    1 Citations
    Phacomatosis melanocesioflammea: the rediscovery of phacomatosis pigmentovascularis type IV
    • D. Torchia
    • Medicine
    • International journal of dermatology
    • 2020

    References

    SHOWING 1-10 OF 20 REFERENCES
    Cheilitis Granulomatosa: A Review
    • 53
    Phacomatosis pigmentovascularis revisited and reclassified.
    • 182
    • PDF